NCT00768586

Brief Summary

The aim of this study is to collect data on the early visual development of extreme premature infants. The method is the measurement of flash visual evoked potentials and the study population includes premature infants under the 28th weeks of gestation, who have normal cranial ultrasound examinations, normal aEEG, no clinical neurological symptoms and who have a normal ophthalmological status. fVEP measurements were recorded from the first week of life every second week until term. The fVEP recordings were performed in active sleep, in stable premature infants, who were continuously monitored. The Nihon Kohden Neuropack 8 was used, the stimulus frequency was 0,5 Hz, artefact free averages were analyzed. The measurements were analyzed according to the presence and absence of known waveforms, their latencies and amplitudes. Longitudinal analysis was performed to analyse the effect of extrauterine visual development on fVEP with growing gestational ages.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

October 7, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 8, 2008

Completed
Last Updated

October 15, 2008

Status Verified

September 1, 2008

First QC Date

October 7, 2008

Last Update Submit

October 14, 2008

Conditions

Outcome Measures

Primary Outcomes (1)

  • Latency and Amplitude of Visual Evoked Potential waveforms measured in the first week of life than every second week prospectively until term.

    Until term

Study Arms (1)

1

Extreme premature infants under the 28th week of gestation.

Eligibility Criteria

Age23 Weeks - 29 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Premature infants between the 23-29th week of gestation are included.

You may qualify if:

  • All premature infants under the 29th week of gestation entering our ward.

You may not qualify if:

  • Infants with intracranial abnormalities, cerebral malformations, neurological symptoms or known eye pathology.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University Vienna, Department of Pediatrics, Neonatology

Vienna, 1090, Austria

RECRUITING

Study Officials

  • Manfred Weninger, MD, PhD.

    MUV

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 7, 2008

First Posted

October 8, 2008

Study Start

February 1, 2008

Last Updated

October 15, 2008

Record last verified: 2008-09

Locations